Delivery Order SPE2DB22D2006-SPE2DB25FW0BM

Award Date 4/16/25
Potential Completion Date 4/17/25
Potential Value $4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $5,047.10, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) for 4,567,996,497 units of the vaccine PRIORIX VIALS, with a completion date of April 23, 2025. The contract is a Firm Fixed Price (FFP) arrangement and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a substantial Indefinite Delivery...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,945.64 Firm Fixed Price Delivery Order is for the supply of 4,568,055,075 units of the PRIORIX VIALS vaccine. The contract has an ultimate completion date of April 29, 2025 and is not a set-aside award. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,599,158 units of the PRIORIX vaccine. The contract has an award date of August 27, 2024, an ultimate completion date of August 28, 2024, and a ceiling value of $17,564.40. The contract is a firm fixed-price delivery order, with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with federal...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,480 units of the PRIORIX vaccine. The firm-fixed-price contract has a ceiling value of $4,733.67 and a completion date of August 19, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This federal contract award, with ID SPE2DB22D2211|SPE2DB25FRWHU, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,009.42 firm fixed-price delivery order is for the supply of 4,568,093,454 vials of the vaccine PRIORIX, with a performance period ending on May 1, 2025. Amerisourcebergen Drug Corp, the prime contractor, is a for-profit organization headquartered in Conshohocken,...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,009.42, is for the delivery of PRIORIX vials, a vaccine product. It is a firm fixed-price delivery order contract type, with a completion date of March 13, 2025. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This is a $4,391.10 firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of PRIORIX vaccine vials. The contract has an ultimate completion date of September 6, 2024. AmerisourceBergen holds several indefinite delivery contracts (IDCs) with federal agencies, including a $999,999,999 IDC with DLA Troop Support Medical for delivering a comprehensive range of medical...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $17,913.60 firm fixed-price delivery order is for the PRIORIX vaccine product. The contract has an ultimate completion date of August 23, 2024. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,159.60, is for the delivery of PRIORIX vaccine vials. The contract has an ultimate completion date of December 17, 2024 and a firm fixed price pricing type. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,087.32 Firm Fixed Price delivery order is for the supply of PRIORIX VIALS, a vaccine product. The contract has an ultimate completion date of November 7, 2023 and was awarded on November 6, 2023. This award is associated with a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB22D2006
    Indefinite Delivery Contract
  • SPE2DB22D2006-SPE2DB25FW0BM
    Delivery Order

This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $4,017.09 firm fixed-price delivery order is for the supply of 4,567,944 vials of the vaccine PRIORIX. The contract has an ultimate completion date of April 17, 2025 and is not set aside. Amerisourcebergen Drug Corp also holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, providing a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 7/16/25, 12:10 PM